Satrajit Roychoudhury: h-index, Total Citations, and Citation Map
Satrajit Roychoudhury's h-index is 23 (37 i10-index, 23,568+ total citations across 97+ publications) according to Google Scholar as of June 2026. Satrajit Roychoudhury is affiliated with Pfizer Inc.
Satrajit Roychoudhury is a researcher affiliated with Pfizer Inc, specializing in Statistics, Biostatistics, Clinical Trials. Their work has been cited 23,568 times. This profile visualizes their global influence, highlighting strong citation networks in China.
Satrajit Roychoudhury's Citation Metrics
Bibliometric impact based on 97 indexed publications.
- H-Index
- 23
- i10-Index
- 37
- Total Citations
- 23,568
- Citing Countries
- 4
As of June 2026.
Satrajit Roychoudhury has an h-index of 23 and 23,568 total citations across 97 publications, with research cited by institutions in 4 countries.
Download Exports (PNG, CSV, Poster)
Free Viewing Satrajit Roychoudhury's citation map is always free. Pay once to download poster, PNG, and CSV files for offline use or your visa packet.
We've mapped 5,000 of 23,568 citations for Satrajit Roychoudhury
We've shown the most-cited 5,000. Unlock the full crawl (23,518 more citations) to see every institution citing this scholar.
Global Impact Map
Visualizing the geographic distribution of institutions that have cited your work.
Starting…
Pins will appear here as institutions are resolved — no need to refresh.
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
202018,697
Top Citing Countries
Top Citing Institutions
Visa Evidence Package
Views and exports tuned for EB-1A, O-1A, and EB-2 NIW petitions. Sustained acclaim, geographic reach, and independent-citation filtering are the strongest evidence categories immigration adjudicators look for.
Citation trend (last 10 years)Click to expand
Citation Trend (Last 10 Years)
Related Guides
Learn how to use citation maps for your research and visa applications.
About Satrajit Roychoudhury's research
Satrajit Roychoudhury is a researcher in Statistics, Biostatistics and Clinical Trials at Pfizer Inc. Their work has been cited 23,568 times across 97 publications (h-index 23), according to Google Scholar.
Their most-cited work, “Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine” (2020), has accumulated 18,697 citations. Other influential works include “Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months” (2021) with 1,788 citations and “Use of historical control data for assessing treatment effects in clinical trials” (2014) with 647 citations.
Citations of Satrajit Roychoudhury's research come primarily from China, Denmark and South Korea, reflecting international research impact across 4+ countries. The interactive citation map above shows the full geographic distribution of the institutions citing this work.
